VIVAZEN® Applauds Kentucky’s Leadership in Protecting Consumers from Synthetic 7-Hydroxymitragynine (7-OH)
VIVAZEN®, a leading botanical wellness company specializing in natural, full-spectrum kratom products, expressed strong support for Kentucky Governor Andy Beshear and Health and Family Services Secretary Dr. Steven Stack following the announcement that the state will move to classify isolated and concentrated forms of 7-hydroxymitragynine (7-OH) as Schedule I narcotics.
Vivazen® Reports Positive Results from Stress Relief Real-World Study*
Vivazen® today announced results from a 21-day at-home real-world study evaluating its Stress Relief* product, conducted in partnership with MoreBetter® and the Network of Applied Pharmacognosy (NAP). The study assessed participants' daily stress levels, mood, and quality of life before and during product use.
VIVAZEN® Applauds Florida’s Emergency Ban on Synthetic 7-OH, Reinforces Commitment to Safe, Natural Kratom
VIVAZEN®, a leading botanical wellness brand, today praised the Florida Attorney General’s emergency scheduling of synthetic 7-hydroxymitragynine (7-OH), calling the targeted action a public health win that protects consumers while preserving access to responsibly formulated kratom products.
VIVAZEN® and MoreBetter® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness
VIVAZEN®, a trusted leader in botanical-based wellness products, proudly shares the results of a first-of-its-kind Real-World Evidence (RWE) study using its proprietary extract. The study was conducted in partnership with MoreBetter®, a leading real-world data and research platform. The study tracked the daily experiences of real users over 21 days and revealed statistically significant improvements in energy, focus, and productivity without the use of caffeine or stimulants.*
